UCSF Brain Tumor Center Clinical Trials
Our clinical trials evaluate a broad range of innovative therapies for both adults and children with brain tumors.
-
Recruiting
- Pediatrics
- On Hold
Conditions
Glioblastoma
Glioma
This is a multicenter phase III clinical trial comparing the combination of an implanted focused ultrasound device and carboplatin chemotherapy versus the standard-of-care second line chemotherapy with either lomustine or temozolomide.
Conditions
Glioma
Glioblastoma
This is a randomized, double-blind, placebo-controlled study designed to examine the impact of a custom-formulated, high CBD product on measures of anxiety, quality of life, and tumor progression and imaging stability in newly-diagnosed glioblastoma patients.
Conditions
Glioma
Astrocytoma
Glioblastoma
Pleomorphic xanthoastrocytoma (grades II-III)
The phase I trial will evaluate the safety and efficacy of nivolumab and ipilimumab before and after surgery in treating children and young adults with recurrent or progressive high grade glioma.
Conditions
Ependymoma
This is a single arm, 2 strata multi-center study that will be conducted through the Pacific Pediatric Neuro-Oncology Consortium (PNOC).
Stratum A: children (ages 3-17) with recurrent or progressive malignant brain tumors